Search

everythinglearnresearchcommunity

for

Search:↓

Eating a balanced diet with the right vitamins and minerals is important for healthy hair, but too many supplements can be harmful.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

A new wearable LED device helps heal chronic infected wounds at home.

Type I interferons play a key role in the development of various skin diseases.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tridax procumbens plant parts boost immune response in mice.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

PRP shows promise in tissue repair but its effectiveness in otolaryngology is still debated.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

The document explains the genetic causes and characteristics of inherited hair disorders.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.